
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugate therapies. Our pipeline includes varegacestat, a late-clinical stage GSI; IM-1021, a clinical-stage ROR1 ADC; and IM-3050, a FAP-targeted radiotherapy that recently received IND clearance. We are also advancing a broad portfolio of early stage ADCs pursuing undisclosed solid tumor targets.
Immunome is a clinical-stage targeted oncology company committed to developing first- and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, including antibody-drug conjugates (ADCs), small molecules, and other targeted modalities, supported by a team with deep experience in the discovery, development, and commercialization of oncology medicines.
Immunome is seeking a highly organized and detail-oriented Sr. Procurement Coordinator to support day-to-day purchasing activities across the organization. This is a part-time contract position (estimated 20 hours/week) and will focus on processing purchase requests, coordinating vendor onboarding, tracking orders and deliveries, and maintaining accurate procurement documentation.
The successful candidate will bring prior experience supporting procurement and purchasing operations, strong attention to detail, and the ability to partner effectively with cross-functional teams and external suppliers. This role will help ensure timely acquisition of goods and services needed to advance Immunome’s research and development programs while maintaining compliance with internal policies and quality expectations.
Responsibilities
Procurement Operations
Vendor and Stakeholder Support
Systems, Reporting, and Process Improvement
Collaboration and Service Orientation
Qualifications
Knowledge and Skills
WA State Contract Pay Transparency (Hourly Rate) $39.51—$49.61 USD
E/E/O
Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
E-Verify
Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish)

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.